Zdrowie i gospodarka · 19/03/2012
FDA Proposes Changes to Diagnostic Devices for Tuberculosis Detection
The FDA is proposing to reclassify nucleic acid-based diagnostic devices for detecting Mycobacterium tuberculosis complex from class III to class II, allowing for faster market approval and use as an aid in diagnosing pulmonary tuberculosis.
Source: Federal Register — Food and Drug AdministrationOpen original release →